OptumRx — Interest Expense, Operating and Nonoperating

Business Segments · Interest Expense, Operating and Nonoperating

This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ2 2021
Last reportedQ3 2025
Rolls up toInterest Expense

How to read this metric

An increase may indicate higher debt levels or rising interest rates, which can negatively impact the segment's net profitability.

Detailed definition

The total interest costs associated with debt or financing activities allocated to the pharmacy benefit management segme...

Peer comparison

Standard interest expense reporting for business segments within large, diversified corporate structures.

Metric ID: unh_segment_optum_rx_interest_expense_operating_and_nonoperating

Historical Data

14 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Range$0.00$0.00

Frequently Asked Questions

What is UnitedHealth Group's optumrx — interest expense, operating and nonoperating?
UnitedHealth Group (UNH) reported optumrx — interest expense, operating and nonoperating of $0.00 in Q3 2025.
What does optumrx — interest expense, operating and nonoperating mean?
Total interest costs incurred by the pharmacy benefit management segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.